Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.

van Aerts RMM, Kievit W, D'Agnolo HMA, Blijdorp CJ, Casteleijn NF, Dekker SEI, de Fijter JW, van Gastel M, Gevers TJ, van de Laarschot LFM, Lantinga MA, Losekoot M, Meijer E, Messchendorp AL, Neijenhuis MK, Pena MJ, Peters DJM, Salih M, Soonawala D, Spithoven EM, Visser FW, Wetzels JF, Zietse R, Gansevoort RT, Drenth JPH; DIPAK-1 Investigators.

Gastroenterology. 2019 Apr 22. pii: S0016-5085(19)36711-3. doi: 10.1053/j.gastro.2019.04.018. [Epub ahead of print]

PMID:
31022403
2.

Predicting mortality in patients with suspected sepsis at the Emergency Department; A retrospective cohort study comparing qSOFA, SIRS and National Early Warning Score.

Brink A, Alsma J, Verdonschot RJCG, Rood PPM, Zietse R, Lingsma HF, Schuit SCE.

PLoS One. 2019 Jan 25;14(1):e0211133. doi: 10.1371/journal.pone.0211133. eCollection 2019.

3.

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.

Meijer E, Visser FW, van Aerts RMM, Blijdorp CJ, Casteleijn NF, D'Agnolo HMA, Dekker SEI, Drenth JPH, de Fijter JW, van Gastel MDA, Gevers TJ, Lantinga MA, Losekoot M, Messchendorp AL, Neijenhuis MK, Pena MJ, Peters DJM, Salih M, Soonawala D, Spithoven EM, Wetzels JF, Zietse R, Gansevoort RT; DIPAK-1 Investigators.

JAMA. 2018 Nov 20;320(19):2010-2019. doi: 10.1001/jama.2018.15870.

4.

Identifying cystogenic paracrine signaling molecules in cyst fluid of patients with polycystic kidney disease.

Kenter AT, van Rossum-Fikkert SE, Salih M, Verhagen PCMS, van Leenders GJLH, Demmers JAA, Jansen G, Gribnau J, Zietse R, Hoorn EJ.

Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F204-F213. doi: 10.1152/ajprenal.00470.2018. Epub 2018 Nov 7.

PMID:
30403162
5.

Diagnosing Alport Syndrome: Lessons from the Pediatric Ward.

Vos P, Zietse R, van Geel M, Brooks AS, Cransberg K.

Nephron. 2018;140(3):203-210. doi: 10.1159/000492438. Epub 2018 Sep 13.

PMID:
30212818
6.

Yield of diagnostic tests in unexplained renal hypophosphatemia: a case series.

Bech AP, Hoorn EJ, Zietse R, Wetzels JFM, Nijenhuis T.

BMC Nephrol. 2018 Sep 4;19(1):220. doi: 10.1186/s12882-018-1017-z.

7.

Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population.

Kieboom BCT, Zietse R, Ikram MA, Hoorn EJ, Stricker BH.

Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1166-1173. doi: 10.1002/pds.4636. Epub 2018 Aug 10.

PMID:
30095199
8.

Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver disease.

Lantinga MA, de Sévaux RGL, Gevers TJG, Oyen WJG, de Fijter JW, Soonawala D, Zietse R, Salih M, Casteleijn NF, Spithoven EM, Meijer E, Gansevoort RT, Drenth On Behalf Of The Dipak Consortium JPH.

Neth J Med. 2018 Jul;76(5):226-234.

9.

Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone.

Moes AD, Severs D, Verdonk K, van der Lubbe N, Zietse R, Danser AHJ, Hoorn EJ.

Front Physiol. 2018 May 18;9:578. doi: 10.3389/fphys.2018.00578. eCollection 2018.

10.

Standard process-oriented workflow introduces pre-analytical error when used in large study sample batches.

Kieboom BCT, Hoorn EJ, Ramakers C, van Rooij FJA, Ikram MA, Hofman A, van Duijn CM, Heeringa J, Zietse R, Peeters RP, Stricker BH, de Rijke YB.

Clin Chem Lab Med. 2018 Nov 27;56(12):e277-e279. doi: 10.1515/cclm-2018-0295. No abstract available.

PMID:
29858899
11.

Increased Urinary Extracellular Vesicle Sodium Transporters in Cushing Syndrome With Hypertension.

Salih M, Bovée DM, van der Lubbe N, Danser AHJ, Zietse R, Feelders RA, Hoorn EJ.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2583-2591. doi: 10.1210/jc.2018-00065.

PMID:
29726949
12.

[Hydration to prevent contrast-induced nephropathy].

Hoorn EJ, Zietse R.

Ned Tijdschr Geneeskd. 2018;161:D2442. Dutch.

PMID:
29328017
13.

Serum magnesium is associated with the risk of dementia.

Kieboom BCT, Licher S, Wolters FJ, Ikram MK, Hoorn EJ, Zietse R, Stricker BH, Ikram MA.

Neurology. 2017 Oct 17;89(16):1716-1722. doi: 10.1212/WNL.0000000000004517. Epub 2017 Sep 20.

PMID:
28931641
14.

The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease.

D'Agnolo HMA, Casteleijn NF, Gevers TJG, de Fijter H, van Gastel MDA, Messchendorp AL, Peters DJM, Salih M, Soonawala D, Spithoven EM, Visser FW, Wetzels JFM, Zietse R, Gansevoort RT, Drenth JPH.

Am J Nephrol. 2017;46(3):239-248. doi: 10.1159/000479436. Epub 2017 Sep 8.

PMID:
28881341
15.

Urinary renin-angiotensin markers in polycystic kidney disease.

Salih M, Bovée DM, Roksnoer LCW, Casteleijn NF, Bakker SJL, Gansevoort RT, Zietse R, Danser AHJ, Hoorn EJ.

Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F874-F881. doi: 10.1152/ajprenal.00209.2017. Epub 2017 Jul 26.

16.

Hyponatraemia diagnosis and treatment clinical practice guidelines.

Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, van Biesen W, Nagler E, Gonzalez-Espinoza L, Ortiz A; Hyponatraemia Guideline Development Group.

Nefrologia. 2017 Jul - Aug;37(4):370-380. doi: 10.1016/j.nefro.2017.03.021. Epub 2017 Jun 12. English, Spanish.

17.

NaCl cotransporter abundance in urinary vesicles is increased by calcineurin inhibitors and predicts thiazide sensitivity.

Tutakhel OAZ, Moes AD, Valdez-Flores MA, Kortenoeven MLA, Vrie MVD, Jeleń S, Fenton RA, Zietse R, Hoenderop JGJ, Hoorn EJ, Hilbrands L, Bindels RJM.

PLoS One. 2017 Apr 21;12(4):e0176220. doi: 10.1371/journal.pone.0176220. eCollection 2017.

18.

Chlorthalidone Versus Amlodipine for Hypertension in Kidney Transplant Recipients Treated With Tacrolimus: A Randomized Crossover Trial.

Moes AD, Hesselink DA, van den Meiracker AH, Zietse R, Hoorn EJ.

Am J Kidney Dis. 2017 Jun;69(6):796-804. doi: 10.1053/j.ajkd.2016.12.017. Epub 2017 Mar 1.

PMID:
28259499
19.

Serum magnesium and the risk of prediabetes: a population-based cohort study.

Kieboom BCT, Ligthart S, Dehghan A, Kurstjens S, de Baaij JHF, Franco OH, Hofman A, Zietse R, Stricker BH, Hoorn EJ.

Diabetologia. 2017 May;60(5):843-853. doi: 10.1007/s00125-017-4224-4. Epub 2017 Feb 21.

20.

Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines.

Hoorn EJ, Zietse R.

J Am Soc Nephrol. 2017 May;28(5):1340-1349. doi: 10.1681/ASN.2016101139. Epub 2017 Feb 7. Review.

21.

Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study.

Lantinga MA, D'Agnolo HM, Casteleijn NF, de Fijter JW, Meijer E, Messchendorp AL, Peters DJ, Salih M, Spithoven EM, Soonawala D, Visser FW, Wetzels JF, Zietse R, Drenth JP, Gansevoort RT; DIPAK Consortium.

Drug Saf. 2017 Feb;40(2):153-167. doi: 10.1007/s40264-016-0486-x.

22.

Proteomics of Urinary Vesicles Links Plakins and Complement to Polycystic Kidney Disease.

Salih M, Demmers JA, Bezstarosti K, Leonhard WN, Losekoot M, van Kooten C, Gansevoort RT, Peters DJ, Zietse R, Hoorn EJ; DIPAK Consortium.

J Am Soc Nephrol. 2016 Oct;27(10):3079-3092. Epub 2016 Mar 3.

23.

On the Origin of Urinary Renin: A Translational Approach.

Roksnoer LC, Heijnen BF, Nakano D, Peti-Peterdi J, Walsh SB, Garrelds IM, van Gool JM, Zietse R, Struijker-Boudier HA, Hoorn EJ, Danser AH.

Hypertension. 2016 May;67(5):927-33. doi: 10.1161/HYPERTENSIONAHA.115.07012. Epub 2016 Feb 29.

24.

Bone Mineral Density in Sjögren Syndrome Patients with and Without Distal Renal Tubular Acidosis.

Both T, Zillikens MC, Hoorn EJ, Zietse R, van Laar JA, Dalm VA, van Duijn CM, Versnel MA, Maria NI, van Hagen PM, van Daele PL.

Calcif Tissue Int. 2016 Jun;98(6):573-9. doi: 10.1007/s00223-016-0112-z. Epub 2016 Feb 12.

25.

An immunoassay for urinary extracellular vesicles.

Salih M, Fenton RA, Knipscheer J, Janssen JW, Vredenbregt-van den Berg MS, Jenster G, Zietse R, Hoorn EJ.

Am J Physiol Renal Physiol. 2016 Apr 15;310(8):F796-F801. doi: 10.1152/ajprenal.00463.2015. Epub 2016 Jan 28.

26.

Serum Magnesium and the Risk of Death From Coronary Heart Disease and Sudden Cardiac Death.

Kieboom BC, Niemeijer MN, Leening MJ, van den Berg ME, Franco OH, Deckers JW, Hofman A, Zietse R, Stricker BH, Hoorn EJ.

J Am Heart Assoc. 2016 Jan 22;5(1). pii: e002707. doi: 10.1161/JAHA.115.002707.

27.

Drug-induced Fanconi syndrome associated with fumaric acid esters treatment for psoriasis: a case series.

Balak DM, Bouwes Bavinck JN, de Vries AP, Hartman J, Neumann HA, Zietse R, Thio HB.

Clin Kidney J. 2016 Feb;9(1):82-9. doi: 10.1093/ckj/sfv114. Epub 2015 Nov 10.

28.

Urinary extracellular vesicles as markers to assess kidney sodium transport.

Salih M, Fenton RA, Zietse R, Hoorn EJ.

Curr Opin Nephrol Hypertens. 2016 Mar;25(2):67-72. doi: 10.1097/MNH.0000000000000192. Review.

PMID:
26717312
29.

Gut-kidney kaliuretic signaling: looking forward to feeding.

Hoorn EJ, Zietse R.

Kidney Int. 2015 Dec;88(6):1230-1232. doi: 10.1038/ki.2015.272.

PMID:
26649662
30.

Renal Toxicity of Concomitant Exposure to Tenofovir and Inhibitors of Tenofovir's Renal Efflux Transporters in Patients Infected With HIV Type 1.

Rokx C, Alshangi H, Verbon A, Zietse R, Hoorn EJ, Rijnders BJ.

J Infect Dis. 2016 Feb 15;213(4):561-8. doi: 10.1093/infdis/jiv466. Epub 2015 Sep 23.

PMID:
26401025
31.

Early home-based group education to support informed decision-making among patients with end-stage renal disease: a multi-centre randomized controlled trial.

Massey EK, Gregoor PJ, Nette RW, van den Dorpel MA, van Kooij A, Zietse R, Zuidema WC, Timman R, Busschbach JJ, Weimar W.

Nephrol Dial Transplant. 2016 May;31(5):823-30. doi: 10.1093/ndt/gfv322. Epub 2015 Aug 31.

PMID:
26330561
32.

Estimation of total kidney volume in autosomal dominant polycystic kidney disease.

Spithoven EM, van Gastel MD, Messchendorp AL, Casteleijn NF, Drenth JP, Gaillard CA, de Fijter JW, Meijer E, Peters DJ, Kappert P, Renken RJ, Visser FW, Wetzels JF, Zietse R, Gansevoort RT; DIPAK Consortium; DIPAK Consortium.

Am J Kidney Dis. 2015 Nov;66(5):792-801. doi: 10.1053/j.ajkd.2015.06.017. Epub 2015 Jul 31.

PMID:
26235803
33.

Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.

Kieboom BC, Kiefte-de Jong JC, Eijgelsheim M, Franco OH, Kuipers EJ, Hofman A, Zietse R, Stricker BH, Hoorn EJ.

Am J Kidney Dis. 2015 Nov;66(5):775-82. doi: 10.1053/j.ajkd.2015.05.012. Epub 2015 Jun 26.

PMID:
26123862
34.

A series of patients with minimal change nephropathy treated with rituximab during adolescence and adulthood.

Dekkers MJ, Groothoff JW, Zietse R, Betjes MG.

BMC Res Notes. 2015 Jun 26;8:266. doi: 10.1186/s13104-015-1255-0.

35.

CD4-Positive T Cells and M2 Macrophages Dominate the Peritoneal Infiltrate of Patients with Encapsulating Peritoneal Sclerosis.

Habib SM, Abrahams AC, Korte MR, Zietse R, de Vogel LL, Boer WH, Dendooven A, Clahsen-van Groningen MC, Betjes MG.

PLoS One. 2015 Apr 24;10(4):e0120174. doi: 10.1371/journal.pone.0120174. eCollection 2015.

36.

Long-term sequelae of severe acute kidney injury in the critically ill patient without comorbidity: a retrospective cohort study.

Fortrie G, Stads S, Aarnoudse AJ, Zietse R, Betjes MG.

PLoS One. 2015 Mar 23;10(3):e0121482. doi: 10.1371/journal.pone.0121482. eCollection 2015.

37.

Prevalence of distal renal tubular acidosis in primary Sjögren's syndrome.

Both T, Hoorn EJ, Zietse R, van Laar JA, Dalm VA, Brkic Z, Versnel MA, van Hagen PM, van Daele PL.

Rheumatology (Oxford). 2015 May;54(5):933-9. doi: 10.1093/rheumatology/keu401. Epub 2014 Oct 29.

PMID:
25354755
38.

Calcineurin inhibitors and hypertension: a role for pharmacogenetics?

Moes AD, Hesselink DA, Zietse R, van Schaik RH, van Gelder T, Hoorn EJ.

Pharmacogenomics. 2014 Jun;15(9):1243-51. doi: 10.2217/pgs.14.87. Review.

PMID:
25141899
39.

Conscious versus unconscious thinking in the medical domain: the deliberation-without-attention effect examined.

Bonke B, Zietse R, Norman G, Schmidt HG, Bindels R, Mamede S, Rikers R.

Perspect Med Educ. 2014 Jun;3(3):179-89. doi: 10.1007/s40037-014-0126-z.

40.

Risk of hyponatremia with diuretics: chlorthalidone versus hydrochlorothiazide.

van Blijderveen JC, Straus SM, Rodenburg EM, Zietse R, Stricker BH, Sturkenboom MC, Verhamme KM.

Am J Med. 2014 Aug;127(8):763-71. doi: 10.1016/j.amjmed.2014.04.014. Epub 2014 May 5.

PMID:
24811554
41.

Methodologic issues in the measurement of urinary renin.

Roksnoer LC, Verdonk K, Garrelds IM, van Gool JM, Zietse R, Hoorn EJ, Danser AH.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1163-7. doi: 10.2215/CJN.12661213. Epub 2014 Apr 17.

42.

Urinary extracellular vesicles and the kidney: biomarkers and beyond.

Salih M, Zietse R, Hoorn EJ.

Am J Physiol Renal Physiol. 2014 Jun 1;306(11):F1251-9. doi: 10.1152/ajprenal.00128.2014. Epub 2014 Apr 2. Review.

43.

Olfactory Neuroblastoma With Hyponatremia.

Hoorn EJ, Monserez DA, Fenton RA, Overdevest I, Apperloo AJ, Zietse R, Hardillo JA.

J Clin Oncol. 2015 Jul 20;33(21):e88-92. doi: 10.1200/JCO.2013.49.1464. Epub 2014 Mar 31. No abstract available.

PMID:
24687825
44.

Everything you need to know about distal renal tubular acidosis in autoimmune disease.

Both T, Zietse R, Hoorn EJ, van Hagen PM, Dalm VA, van Laar JA, van Daele PL.

Rheumatol Int. 2014 Aug;34(8):1037-45. doi: 10.1007/s00296-014-2993-3. Epub 2014 Mar 29. Review.

45.

Clinical practice guideline on diagnosis and treatment of hyponatraemia.

Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, Van Biesen W, Nagler E; Hyponatraemia Guideline Development Group.

Nephrol Dial Transplant. 2014 Apr;29 Suppl 2:i1-i39. doi: 10.1093/ndt/gfu040. Epub 2014 Feb 25. Erratum in: Nephrol Dial Transplant. 2014 Jun;40(6):924.

PMID:
24569496
46.

Clinical practice guideline on diagnosis and treatment of hyponatraemia.

Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, Van Biesen W, Nagler E; Hyponatraemia Guideline Development Group.

Eur J Endocrinol. 2014 Feb 25;170(3):G1-47. doi: 10.1530/EJE-13-1020. Print 2014 Mar. Erratum in: Eur J Endocrinol. 2014 Jul;171(1):X1.

PMID:
24569125
47.

Clinical practice guideline on diagnosis and treatment of hyponatraemia.

Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, Van Biesen W, Nagler E.

Intensive Care Med. 2014 Mar;40(3):320-31. doi: 10.1007/s00134-014-3210-2. Epub 2014 Feb 22. Erratum in: Intensive Care Med. 2014 Jun;40(6):924. Hoorn, Ewout [corrected to Hoorn, Ewout J].

PMID:
24562549
48.

In Memoriam: Stanley Shaldon, MD, FRCP, 1931-2013.

Kaplan AA, Davenport A, Zietse R, Tesar V.

Blood Purif. 2014;37(1):73-5. doi: 10.1159/000358369. Epub 2014 Feb 15. No abstract available.

PMID:
24556950
49.

[Hyponatraemia: ask the right questions].

Hoorn EJ, Kaasjager KA, Zietse R.

Ned Tijdschr Geneeskd. 2014;158(5):A7139. Review. Dutch.

PMID:
24472340
50.

Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease.

Meijer E, Drenth JP, d'Agnolo H, Casteleijn NF, de Fijter JW, Gevers TJ, Kappert P, Peters DJ, Salih M, Soonawala D, Spithoven EM, Torres VE, Visser FW, Wetzels JF, Zietse R, Gansevoort RT; DIPAK Consortium.

Am J Kidney Dis. 2014 Mar;63(3):446-55. doi: 10.1053/j.ajkd.2013.10.011. Epub 2013 Dec 15.

Supplemental Content

Loading ...
Support Center